Sperm bank market to hit $6.9 billion by 2033

Persistence Market Research says the global sperm bank market will grow from $5.3 billion in 2026 to $6.9 billion by 2033, driven by fertility preservation, assisted reproductive technologies and rising infertility rates. North America leads now, while donor sperm services and fertility clinics remain the biggest demand centers.

Why it matters: - Sperm banking is becoming a bigger part of fertility care as more people delay parenthood and seek reproductive health solutions. - Demand is rising across infertility treatment, donor insemination and fertility preservation before medical procedures such as chemotherapy. - The market outlook points to more investment in fertility clinics, cryopreservation systems and genetic screening.

What happened: - The global sperm bank market is projected to reach US$ 6.9 billion by 2033, up from US$ 5.3 billion in 2026. - The forecast implies a 3.8% compound annual growth rate from 2026 to 2033. - Persistence Market Research published the outlook on July 23, 2026. - The report says North America currently leads the market. - Donor sperm services remain the largest segment.

The details: - Fertility preservation, assisted reproductive technologies and broader awareness of reproductive health are supporting market growth. - Acceptance of donor insemination is expanding among single parents, LGBTQ+ families and couples facing infertility. - Rising infertility, delayed parenthood and changing lifestyles are increasing demand for sperm banking services. - Improved cryopreservation, specimen storage and donor screening are strengthening treatment quality and long-term sample viability. - Favorable advances in genetic screening are also supporting market expansion. - Fertility clinics are the dominant end-user segment because of higher patient volumes and broader reproductive healthcare services. - Hospitals, specialty reproductive centers and research institutions also contribute to demand. - Digital donor databases and streamlined screening procedures are improving efficiency and patient experience. - The report lists key companies including California Cryobank, Fairfax Cryobank, Cryos International, Xytex Corporation, Seattle Sperm Bank, New England Cryogenic Center, European Sperm Bank, London Sperm Bank, Indian Spermtech and Androcryos. - The report is available with a sample at More information and a customization option at Customize this report. - The full report can be purchased at Buy the full report.

Between the lines: - The market is being shaped by a mix of medical need and changing family planning preferences. - North America’s lead reflects stronger healthcare infrastructure, higher awareness and supportive regulations. - Europe remains an important market, while Asia Pacific is emerging on the back of improving healthcare access, higher disposable income and medical tourism. - Regulatory differences, donor anonymity rules, high treatment costs and limited reimbursement still slow adoption in some regions. - The biggest upside appears to come from technology, especially AI-assisted donor matching, advanced genetic testing and automation in lab operations.

What's next: - Fertility clinics and sperm banks are likely to keep expanding as awareness of reproductive health grows. - The report expects more adoption of digital platforms, advanced lab systems and partnerships across fertility providers and researchers. - Market growth will likely depend on how well providers manage regulation, affordability and access in developing regions.

The bottom line: - Sperm banking is moving from a niche service into a broader fertility-care market, with technology and delayed parenthood driving the next phase of growth.